Navigation Links
RNL BIO Co. Ltd. lämnar in IND-ansökan om att påbörja klinisk fas II-prövning av RNL-JointStem för artros i USA
Date:5/3/2013

ndlingen av artros, så att man istället använder stamcellspreparat framställda ur patientens egen fettvävnad." Bland de viktiga fördelar som visats i tidigare prövningar av RNL-JointStem är att det administreras i en enda injektion, till skillnad från de många invasiva behandlingsterapier som för närvarande används vid behandling av artros. "Behandlingsterapier för denna smärtsamma kroniska åkomma ska lindra värken, inte göra den värre", sa Dr. Ra. "Vi hoppas kunna bekräfta att RNL-JointStem är effektivt för broskregeneration, smärtreduktion och förbättrad ledfunktion för patienter med artros, samt att det med tiden kommer att godkännas på marknaden."

Den kliniska prövningen kommer att jämföra RNL-JointStem med befintliga terapier baserade på hyaluronan. Patientpopulationen för denna inledande prövning kommer att omfatta patienter med diagnosen artros vars läkare anser att de uppfyller kraven för deltagande. Den tänkta marknaden för RNL-JointStem är patienter under 60 år, en grupp för vilka det för närvarande inte finns någon effektiv behandling.

Om artros

Degenerativ artrit är den vanligaste typen av artrit. Det uppskattas att 26,9 miljoner amerikaner i åldern 25 år och över har klinisk degenerativ artrit i någon led och att en ännu högre andel av den äldre delen av befolkningen är drabbade. Exempel på kliniska manifestationer är ledsmärta och nedsatt rörlighet, och den omgivande vävnaden drabbas ofta av lokala inflammationer. De bakomliggande orsakerna till degenerativ artrit är inte helt kartlagda, men skador, ålder och ärftlighet anses tillhöra riskfaktorerna.

Degenerativ artrit är en försvagande sjukdom med progre
'/>"/>

SOURCE RNL BIO
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. RNL BIO har anmält en fas II/III klinisk prövning till KFDA för en behandling av cerebral pares med autologa stamceller framställda från fettvävnad
2. RNL BIO Co. Ltd. Files IND To Commence Phase II Clinical Trial Of RNL-JointStem For Osteoarthritis In The United States
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... BOCA RATON, Fla. , Sept. 2, 2015 ... Cartledge , MD, FACS, has begun performing ultra-minimally ... patients who are on anticoagulants such as Coumadin, ... of Cardiothoracic Surgery at the Hospital, is one ... this method, which involves making two microscopic incisions ...
(Date:9/2/2015)... 2, 2015  Aethlon Medical, Inc. (Nasdaq: AEMD ), ... will be presenting at the Rodman & Renshaw 17th Annual ... at 9:35 a.m. ET on Thursday, September 10, 2015. ... public via live audio webcast which can be accessed by ... at http://www.aethlonmedical.com . The webcast will be archived for ...
(Date:9/2/2015)... TORONTO , Sept. 2, 2015 ... (OTCQB: GNBT) today announced that its previously ... co-development arrangement with CannScience Innovations Inc. ( ... Generex and CannScience have entered into a ... to the Agreement, Generex has licensed its ...
Breaking Medicine Technology:Boca Regional Introduces Ultra-Minimally Invasive Surgical Procedure for Atrial Fibrillation Patients 2Boca Regional Introduces Ultra-Minimally Invasive Surgical Procedure for Atrial Fibrillation Patients 3Generex Announces Formalization of Buccal Cannabis Co-Development Plan 2Generex Announces Formalization of Buccal Cannabis Co-Development Plan 3
(Date:9/2/2015)... ... 2015 , ... The medical waste management market is expected to reach USD ... 5.2%. The global medical waste management market is segmented based on type of waste, ... to register the highest growth rate in the medical waste management market, by service, ...
(Date:9/2/2015)... ... September 02, 2015 , ... Michael Elliot Media announces a crowdfunding ... actress as the primary love interest in the film. The campaign is being called ... affects how and what we think,” Michael Elliot, an award-winning screenwriter and CEO of ...
(Date:9/2/2015)... ... September 02, 2015 , ... ... food banks in commemorating “Hunger Action Month” during the entire month of September. ... Food Bank will be dedicating its efforts this September to an awareness campaign ...
(Date:9/2/2015)... ... September 02, 2015 , ... Since 2011, DoMyOwnPestControl.com ... Atlanta to help support childhood cancer research. On June 17, 2014, the ... Care-A-Thon , which is the fund-raising event DoMyOwnPestControl.com sponsors each year. The very ...
(Date:9/2/2015)... ... September 02, 2015 , ... ... companies, has completed a recapitalization with new investment partners Beecken Petty O’Keefe ... Group each offer extensive expertise and connections within the healthcare industry, which ...
Breaking Medicine News(10 mins):Health News:Medical Waste Management Market Growing at 5.2% CAGR to 2020 2Health News:Medical Waste Management Market Growing at 5.2% CAGR to 2020 3Health News:Medical Waste Management Market Growing at 5.2% CAGR to 2020 4Health News:Medical Waste Management Market Growing at 5.2% CAGR to 2020 5Health News:Award-Winning Screenwriter Uses Crowdfunding Campaign to Change Hollywood’s Ideal of Beauty to Include PLUS-SIZE Women 2Health News:#IfOnlyYouKnew: Alameda County Community Food Bank Commemorates September as National Hunger Action Month 2Health News:#IfOnlyYouKnew: Alameda County Community Food Bank Commemorates September as National Hunger Action Month 3Health News:#IfOnlyYouKnew: Alameda County Community Food Bank Commemorates September as National Hunger Action Month 4Health News:DoMyOwnPestControl.com Goes Gold for Childhood Cancer Awareness Month 2Health News:Medical Solutions Completes Recapitalization with Beecken Petty O’Keefe & Company and Heritage Group 2Health News:Medical Solutions Completes Recapitalization with Beecken Petty O’Keefe & Company and Heritage Group 3Health News:Medical Solutions Completes Recapitalization with Beecken Petty O’Keefe & Company and Heritage Group 4
... North America -, PRINCETON, N.J., Dec. 18 ... Barr has been named Covance,s Chief,Operating Officer, effective ... of Early Development North America, will assume operating,responsibility ... to,Joe Herring, Covance,s Chairman and Chief Executive Officer. ...
... slightly more effective than traditional lung scans, , , TUESDAY, ... a life-threatening blood clot in the lungs -- can ... a technique using CT scanning might be slightly more ... Canadian researchers found that computed tomographic pulmonary angiography (CTPA) ...
... team of researchers led by Mayo Clinic have designed a ... to destroy cancer cells that spread from primary tumors to ... addition, their study shows that this technology could be the ... , The study appeared in the Dec. 9 online issue ...
... screenings for those with severe illnesses, they may bring ... a recent study by Yale School of Medicine researchers ... study offers a new approach for assessing who is ... recommendations can be tailored more effectively to individual patients. ...
... NightHawk,Radiology Holdings, Inc. (Nasdaq: NHWK ), ... and hospitals throughout the United States,today announced that ... Healthcare,Conference, January 10, 2008, at 8:30 a.m. PST ... Paul Berger, Chairman and CEO, Tim Mayleben, President,and ...
... Dec. 18 Psoriasis Cure Now,a nonprofit patient ... an association between severe psoriasis and a significantly,increased ... psoriasis research. The,study, by a team of University ... severe psoriasis have a 50 percent,increased risk of ...
Cached Medicine News:Health News:Wendel Barr Appointed Chief Operating Officer of Covance 2Health News:Wendel Barr Appointed Chief Operating Officer of Covance 3Health News:CT Scans Catch More Clots in Lungs 2Health News:CT Scans Catch More Clots in Lungs 3Health News:Researchers train the immune system to deliver virus that destroys cancer in lab models 2Health News:Researchers train the immune system to deliver virus that destroys cancer in lab models 3Health News:Colon cancer screenings may not pay off and could pose harm to some 2Health News:NightHawk Radiology Holdings, Inc. to Speak at Annual JPMorgan Healthcare Conference on January 10, 2008 2
Histopathology Reference Laboratory provides a full range of histology services, encompassing routine and specialized grossing, processing, embedding, microtomy, routine and special staining and cove...
IBT Reference Laboratory is a national research and specialty clinical lab founded in 1983 that provides a wide range of tests and services in the area of allergy, clinical immunology and molecular b...
Marquette General Health System Reference Laboratory provides a full range of testing including, Chemistry, Hematology, Coagulation, Urinalysis, Microbiology, Cytology, Anatomic Pathology, Flow Cytom...
Headquartered in Burlington, North Carolina, LabCorp has more than 23,500 employees and offers more than 4,400 clinical tests ranging from routine blood analyses to the most sophisticated molecular d...
Medicine Products: